Complete Guide To Computerized System Compliance

Regulated teams often create extensive qualification packages for low-risk systems, even though auditors may show little interest in them. Sion Wyn, a GAMP SIG expert, GAMP 5 editor, and FDA 21 CFR Part 11 advisor, examines why fear still shapes validation practices and how computerized system assurance offers a more focused path. His analysis unpacks the FDA’s September 2025 final guidance, comparing inspection readiness driven by anxiety with an approach grounded in quality and risk. It also clarifies how much confidence teams can place in vendor testing and where their own accountability begins. Insights from the Enabling Innovation Good Practice Guide and the second edition of GAMP 5 further define a practical approach to documentation, testing, and risk-based decision-making.

Access the full ebook to learn more.